TIERNEY COLLINS: Open Payments
NPI 1760921340 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 8 payments from 5 companies in 2025. Trend: 2023 $101 · 2024 $151 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $194 |
| UCB, Inc. | 2 | $50 |
| Chiesi USA, Inc. | 2 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: AMPLATZER TALISMAN, CLEVIPREX, Rystiggo, INFINITY, ONPATTRO, Briviact.
Industry payments across KY — which companies pay providers there.
